Charles Mosseri - Jul 20, 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role: 10%+ Owner
Signature: /s/ Charles Mosseri-Marlio
Stock symbol: NVCT
Transactions as of: Jul 20, 2023
Transactions value $: $119,224
Form type: 4
Date filed: 7/24/2023, 04:45 PM
Previous filing: Jul 20, 2023
Next filing: Jul 27, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCT	Common Stock	Purchase	$77.7K	+5.39K	+0.21%	$14.40	2.58M	Jul 20, 2023	Direct	F1
transaction	NVCT	Common Stock	Purchase	$41.6K	+2.84K	+0.11%	$14.61	2.58M	Jul 21, 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.10 to $14.42. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

Content

Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.10 to $14.42. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.